and luteolin-7-glucoside have shown the strongest antioxidant activity in in vitro tests (16) . Polyphenolic compounds have also shown strong antioxidant activity (14) . The positive effects of these antioxidant components come from their ability to inhibit lipid peroxidation and chelate redox-active metals (17) . There is evidence that flavonoids have anti-phosphodiesterase activity and could thus elevate intracellular levels of cyclic nucleotides (18) . Recent studies indicate that both cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) can diminish oxidative stress in many biological systems and diseases in vivo (19, 20) .
Because of the effect of free radicals on all cellular macromolecules, which result in various diseases, it seemed interesting to study the antioxidant potential of T. polium in vivo.
EXPERIMENTAL

Plant material and total extract
Aerial parts of T. polium were collected during the flowering period in the region of Kerman borders (East Iran). Samples of the plant were identified by a botanist from the Division of Pharmacognosy, Tehran University of Medical Sciences (TUMS), Iran.
The plant material was air dried, powdered and extracted by the percolation method using ethanol (80%). The solvent was removed under vacuum in a rotary evaporator until dryness (14%, m/m, of dry plant).
Chemicals
All chemicals were of highest purity (³ 99.0%). Sodium acetate, 2,4,6-tripyridyl-striazine (TPTZ), 2-thiobarbituric acid (TBA), 1,1,3,3-tetramethoxypropan (MDA), trichloroacetic acid (TCA), glacial acetic acid, 1,1-diphenyl-2-picryl hydrazyl (DPPH), FeCl 36 H 2 O, HCl, and n-butyl alcohol were purchased from Merck Iran. a-Tocopherol (Trolox) was purchased from ACROS organics, Belgium.
Animals and treatment
Experiments were performed on adult male Wistar rats from the Pasteur Institute of Tehran (Iran) weighing 180-200 g. They were kept under standardized conditions (temperature 21-24°C and a light/dark cycle of 12 hours/12 hours) and fed a normal laboratory diet. After 1 week of acclimatization, rats were divided into one control and four experimental groups with 6 animals in each group. The study protocol was approved by the Pharmaceutical Sciences Research Center (PSRC)/TUMS Ethics Committee.
The extract was dissolved in normal saline to provide a 20 mg mL -1 solution. Animals from group 1 to 3 received doses expressed on the basis of mg dry extract per kg body mass, namely 50, 100, and 200 mg kg -1 per day of the extract by intragastric intubation for 14 days. Group 4 received a-tocopherol (10 mg kg -1 per day) dissolved in saline by intragastric intubation as a reference antioxidant for comparison. The fifth group of animals was treated as control and received only saline.
Blood collection
About 4 mL of blood was collected through direct heart puncture from anesthetized rats. Intraperitoneal administration of pentobarbital (60 mg kg -1 ) was used to induce anesthesia in rats. The blood was centrifuged at 2000 × g for 10 minutes to separate serum. The serum was kept at -20°C for subsequent determination of lipid peroxidation and antioxidant status.
Lipid peroxidation assay
Thiobarbituric Acid Reactive Substances (TBARS) assay is the method of choice for screening and monitoring lipid peroxidation, a major indicator of oxidative stress. To precipitate the serum proteins, 2.5 mL of TCA 20% (m/V) was added into 0.5 mL of the sample, which was then centrifuged at 1500 × g for 10 min. Then 2.5 mL of sulfuric acid (0.05 m L -1 ) and 2 mL TBA (0.2%) was added to the sediment, shaken, and incubated for 30 min in a boiling water bath. Then, 4 mL n-butanol was added, and the solution was centrifuged, cooled and the supernatant absorption was recorded at 532 nm using a UV-Visible spectrophotometer (Shimadzu, Japan). The calibration curve was obtained using different concentrations of 1,1,3,3-tetramethoxypropane as standard to determine the concentration of TBA-MDA adducts in samples (21) .
Total antioxidant power (TAP) assay
The total antioxidant capacity of serum was determined by measuring its ability to reduce Fe 3+ to Fe 2+ by the FRAP (Ferric Reducing Ability of Plasma) test. The FRAP assay measures the change in absorbance at 593 nm owing to the formation of a blue colored Fe(II)-tripyridyltriazine compound from Fe(III) by the action of electron donating antioxidants. The FRAP reagent consists of 300 mmol L -1 acetate buffer pH = 3.6, 10 mmol L -1 TPTZ in 40 mmol L -1 HCl and 20 mmol L -1 FeCl 3´6 H 2 O in the ratio of 10:1:1. Briefly, 10 mL of serum was added to 300 mL freshly prepared and prewarmed (37°C) FRAP reagent in a test tube and incubated at 37°C for 10 min. The absorbance of the blue colored complex was read against a reagent blank (300 mL FRAP reagent + 10 mL distilled water) at 593 nm. Standard solutions of Fe 2+ in the range of 100 to 1000 mmol L -1 were prepared from ferrous sulphate (FeSO 4´7 H 2 O) in water. The data was expressed as mmol ferric ions reduced to ferrous form per liter (FRAP value) (22) .
DPPH radical scavenging activity
In this test, serum ability to inhibit DPPH radical was measured (23) . DPPH is one of the few stable organic nitrogen radicals and has a maximum of absorption at 517 nm. 20 mL of rat's serum was added to 3 mL of DPPH solution (0.1 mmol L -1 in ethanol) and the reaction mixture was shaken vigorously. After incubation at room temperature for 10 min, the absorbance of this solution was determined at 517 nm DPPH solutions without serum and with a-tocopherol were used as the control and reference, respectively.
Determination of LD 50
In order to determine the acute toxicity (LD 50 ) of T. polium, doses of 10, 100, 1000, and 2000 mg kg -1 of the day extract were administrated to rats via intragastric tube. The animals were observed for 48 h and mortality was recorded at the end of this period (24) .
Statistical analysis
The values are reported as mean ± SEM. One-way ANOVA and Tukey posthoc multicomparison tests were used for data analysis.
RESULTS AND DISCUSSION
The acute toxicity test (LD 50 ) demonstrated that T. polium extract is not lethal up to a dose of 2000 mg kg -1 .
T. polium extracts in all doses (mg kg -1 ) used significantly (p < 0.05) increased the serum DPPH scavenging potential when compared to the control as follows: 50 (786%), 100 (907%), 200 (779%). This value for a-tocopherol (10 mg kg -1 ) compared to the control was 667% (p < 0.05) (Fig. 1a) . T. polium extract in the same doses (mg kg -1 ), significantly (p < 0.005) increased the serum TAP when compared to the control as follows: 50 (23.6%), 100 (37.5%) (Fig. 1b) and decreased the serum TBARS when compared to the control as follows: 50 (24.7%), 100 (31.8%) (Fig. 1c) . This value for a-tocopherol (10 mg kg -1 ) compared to the control in the TAP assay was 16.8% (p < 0.05) and in the TBARS assay 29.5% (p < 0.05). T. polium at a dose of 200 mg kg -1 per day did not significantly alter the serum TAP and TBARS. Data obtained by DPPH, FRAP, and TBARS assays indicate that T. polium effectively inhibits oxidative stress in vivo. When tested by FRAP and TBARS, T. polium extract at a dose of 200 mg kg -1 per day exhibited no significant antioxidant activity in comparison to the control. It is proposed that the DPPH test is more sensitive than FRAP and TBARS tests for examination of the antioxidant capacity of T. polium.
Results of the present in vivo study are supported by the work of Panovska and Kulevanova (7) indicating that diethyl ether, ethyl acetate and n-butanol extracts of T. species inhibit lipid peroxidation in vitro. In addition, they indicated that the inhibitory effect of the extracts was greater than that of reference substances such as luteolin, and similar to that of thymol and butylated hydroxyl toluene. Regarding the presence of flavonoids and polyphenolic compounds such as cirsimaritin, apigenin-7-glucoside, vicenin, and luteolin-7-glucoside in the T. polium extract (15, 16) , the obtained in vivo results are not surprising. As mentioned earlier, T. polium has been recognized in folk medicine in the treatment of diabetes (6) . Regarding the role of oxidative stress in the pathogenesis of diabetes (26), the benefit of T. polium in diabetes seems reasonable.
CONCLUSIONS
This preliminary study indicates the interesting antioxidative stress potential of T. polium in vivo that is comparable to that of a-tocopherol. Further studies are needed to elucidate whether T. polium could be useful in the management of human diseases resulting from oxidative stress.
S A @ E T A K
In vivo antioksidativni potencijal biljke Teucrium polium u usporedbi s a-tokoferolom PARISA HASANI, NARGUES YASA, SANAZ VOSOUGH-GHANBARI, AZADEH MOHAMMADIRAD, GHOLAMREZA DEHGHAN i MOHAMMAD ABDOLLAHI U okviru ovih istra`ivanja ispitan je antioksidativni potencijal biljke Teucrium polium (Lamiaceae) in vivo. Antioksidativni u~inak mjeren je pomo}u tri testa koji uklju~uju inhibiciju 1,1-difenil-2-pikrilhidrazil (DPPH) radikala, ukupnu antioksidativnu snagu (TAP) i reaktivne supstancije tiobarbiturne kiseline (TBARS) u serumu. [takorima je davan suhi ekstrakt T. polium u 80%-tnom etanolu intragastri~nom intubacijom u dozama od 50, 100 i 200 mg kg -1 dnevno tijekom 14 dana. Pokusi su pokazali zna~ajno antioksidativno djelovanje T. polium DPPH testom u usporedbi s kontrolom. T. polium je u dozama od 50 i 100 mg kg -1 zna~ajno povisio TAP i snizio TBARS u usporedbi s kontrolom. Primjena ekstrakta T. polium u dozi od 200 mg kg -1 dnevno nije zna~ajno mijenjala serumske TAP i TBARS vrijednosti. Antioksidativni u~inak T. polium u dozama 50 i 100 mg kg -1 bio je u svim eksperimentima sli~an u~incima a-tokoferola (10 mg kg -1 ).
Preliminarna ispitivanja ukazuju na antistresni u~inak T. polium koji je usporediv antioksidativnom u~inku. Me|utim, potrebna su daljnja ispitivanja da se rasvijetli bi li T. polium mogla biti korisna u uklanjanju posljedica oksidativnog stresa. 
